Jonathan D Licht

Jonathan D Licht, MD

DIR & PROF

Department: MD-HEMATOLOGY/ONCOLOGY-ONCOL
Business Phone: (352) 273-8143

About Jonathan D Licht

Dr. Licht is the director of the UF Health Cancer Center, holding the Marshall E. Rinker, Sr. Foundation and David B. and Leighan R. Rinker Chair. Previously Dr. Licht was Chief of Hematology/Oncology at Northwestern University and an Associate Director of the Robert H. Lurie Comprehensive Cancer Center. NCI funded for nearly 25 years, Dr. Licht is also Principal Investigator of a Leukemia and Lymphoma Society Specialized Center and a Multiple Myeloma Research Foundation program grant. He is an investigator in the Dana-Farber SPORE in myeloma and co-leader in a NCI-funded Chicago Physical Sciences Oncology Center. Senior Editor of Clinical Cancer Research, Dr. Licht serves on the editorial boards of Oncogene and Cancer Cell. He’s a member of the executive committee of the American Society of Hematology, and will be co-director of the 2017 ASH/EHA Translational Research Training program. Additionally he sits on the Medical/Scientific Board of the LLS and is a member of the Basic Mechanisms of Cancer Therapeutics Study Section. Dr. Licht has published nearly 170 original articles, reviews and book chapters, and mentors graduate students, postdoctoral fellows and faculty members.

Grants

Mar 2020 ACTIVE
Nuclear Dysfunction in Cancer: The Role of Mechanical Stresses Transmitted by the LINC Complex
NATL INST OF HLTH NCI · Project Manager
Oct 2019 ACTIVE
Targeting Enhancer Dysfunction in Hematological Malignancy
LEUKEMIA & LYMPHOMA SOC · Principal Investigator
Jul 2019 ACTIVE
The role of DNMT3A mutations in clonal heterogeneity and evolution of hematopoiesis
NATL INST OF HLTH NIDDK ·
Jul 2019 ACTIVE
UF Health Cancer Center Pilot Projects funded by UF Foundation Allocated Funds
UF FOU · Principal Investigator
Jul 2019 ACTIVE
The Role of NSD2 Mutation in Therapy Resistance in Childhood Acute Lymphoblastic Leukemia
LEUKEMIA & LYMPHOMA SOC · Mentor
Jul 2019 ACTIVE
Consequences and Vulnerabilities of NSD2 Overexpression in Multiple Myeloma
AMER ASSO FOR CANCER RESEARCH · Mentor
Jul 2019 ACTIVE
SWCRF Institute Without Walls
SAMUEL WAXMAN CANCER RESEARCH FOU · Principal Investigator
Jul 2019 ACTIVE
The role of NSD2 mutation in therapy resistance in childhood ALL
Rally Foundation · Mentor
May 2019 ACTIVE
Development of Diagnostic Tools for Metastatic Melanoma via Imaging of Heparanase Activity
US ARMY MED RES ACQUISITION · Mentor
May 2019 – Apr 2020
Spatio-Temporal Organization of Chromatin and Information Transfer to Cancer
NORTHWESTERN UNIV · Principal Investigator
Jul 2018 ACTIVE
KDM6A mutation as an epigenetic driver of multiple myeloma
LEUKEMIA & LYMPHOMA SOC · Mentor
Jul 2018 – Oct 2018
The Role of NSD2 Methyltransferase in Refractory Acute Lymphocytic Leukemia
AMER ASSO FOR CANCER RESEARCH · Mentor
May 2018 ACTIVE
Identification Of Therapeutic Targets And Pathways In Relapsed Childhood Acute Lymphocytic Leukemia Associated With NSD2 Mutation
FL DEPT OF HLTH · Principal Investigator
May 2018 – Apr 2020
Spatio-Temporal Organization of Chromatin and Information Transfer in Cancer//Modeling of Chromatin Biology of Cancer in Three Dimensional Models
NORTHWESTERN UNIV · Principal Investigator
Apr 2018 ACTIVE
Defining and therapeutically targeting HDAC8-driven reprogramming in melanoma brain metastasis development
H LEE MOFFITT CANCER CTR · Principal Investigator
Mar 2018 ACTIVE
Leveraging CRISPR and CoMMpass data to validate genes driving high-risk MM
DANA FARBER CANCER INST · Principal Investigator
Feb 2018 – Jan 2019
Targeting multiple myeloma with anti-ASCT2 agent MEDI7247
MEDIMMUNE INC · Principal Investigator
Nov 2017 ACTIVE
The Harry T. Mangurian, Jr. Foundation – Support for the Study of Therapy Resistant Leukemia
UF FOU · Principal Investigator
Sep 2017 ACTIVE
UFHCC Triple Negative Breast Cancer (TNBC) Pilot Project Program
MULTIPLE SPONSORS · Principal Investigator
Aug 2017 – Jul 2018
Targeting EZH2 in Germinal Cancer Derived B-Cell Lymphoma
CORNELL UNIV · Principal Investigator
Jul 2017 – Jun 2019
Samuel Waxman Cancer Research Foundation Investigator Award
SAMUEL WAXMAN CANCER RESEARCH FOU · Principal Investigator
Apr 2017 – Dec 2018
MOLECULAR TARGETS OF TRANSLOCATION T(4:14) IN MULTIPLE MYELOMA PATHOGENESIS
UNIV OF IOWA · Principal Investigator
Apr 2017 – Feb 2020
Defining and targeting epigenetic deregulation in uveal melanoma
H LEE MOFFITT CANCER CTR · Principal Investigator
Oct 2016 – Oct 2017
MMSET in the response to DNA Damage and Therapuetic Resistance to Hematological Malignancies
CELGENE CORP · Principal Investigator
Aug 2016 ACTIVE
The Role of MMSET in the Pathogenesis and Progression of Lymphoid Malignancy
NATL INST OF HLTH NCI · Principal Investigator
Aug 2016 – Jul 2017
Targeting EZH2 in Germinal Cancer Derived B-Cell Lymphoma
CORNELL UNIV · Principal Investigator
Jul 2016 – Dec 2017
The Role of MMSET in Relapsed Acute Lymphocytic Leukemia
ST BALDRICKS FOUNDATION · Principal Investigator
Jul 2016 – Jun 2017
Targeting Histone Methylation
SAMUEL WAXMAN CANCER RESEARCH FOU · Principal Investigator
Jun 2016 – Jun 2017
Chromatin dysregulation generated by recurrent point mutation in histone methyltransferase, MMSET, drives progression of lymphoid malignancies
NATL INST OF HLTH NCI · Principal Investigator
Jun 2016 ACTIVE
UTX, MLL AND PATHOGENIC DEREGULATION OF HISTONE METHYLATION IN MULTIPLE MYELOMA
NATL INST OF HLTH NCI · Principal Investigator
Feb 2016 – Aug 2018
SPORE in multiple myeloma
DANA FARBER CANCER INST · Principal Investigator
Jan 2016 ACTIVE
ufhcc-ioa cancer-aging collaborative team grants
UF HEALTH SHANDS HOSPITAL · Principal Investigator
Jan 2016 – Aug 2016
MOLECULAR TARGETS OF TRANSLOCATION T(4:14) IN MULTIPLE MYELOMA PATHOGENESIS
WASHINGTON UNIV · Principal Investigator
Jan 2016 – Jun 2016
Mechanisms of resistance to chromatin targeted drugs: EZH2 inhibitors in B cell malignancies
SAMUEL WAXMAN CANCER RESEARCH FOU · Principal Investigator
Oct 2015 – Apr 2020
Spatio-Temporal Organization of Chromatin and Information Transfer in Cancer
NORTHWESTERN UNIV · Principal Investigator
Oct 2015 – Nov 2019
Chromatin Writers, Readers and Erasers in Multiple Myeloma
MULTIPLE MYELOMA RESEARCH FOU · Principal Investigator
Oct 2015 – Jul 2016
Molecular Targets of Translocation in Multiple Myeloma
NORTHWESTERN UNIV · Principal Investigator
Oct 2015 – Jun 2016
The Role of MMSET in Relapsed Acute Lymphocytic Leukemia
NORTHWESTERN UNIV · Principal Investigator
Oct 2015 – Feb 2016
UTX, MLL AND PATHOGENIC DEREGULATION OF HISTONE METHYLATION IN MULTIPLE MYELOMA
NORTHWESTERN UNIV · Principal Investigator
Oct 2015 – Jan 2016
SPORE in Multiple Myeloma
NORTHWESTERN UNIV · Principal Investigator
Oct 2015 – Sep 2018
Chromatin Mechanisms And Epigenetic Targeting In Hematological Malignancies
LEUKEMIA & LYMPHOMA SOC · Principal Investigator
Jul 2015 ACTIVE
Florida Academic Cancer Center Alliance Seed Grants
UF HEALTH SHANDS HOSPITAL · Principal Investigator
Feb 2015 ACTIVE
UF Health Cancer Center Pilot Project Grants funded through the Florida Consortium of National Cancer Institute Centers Program
UF HEALTH SHANDS HOSPITAL · Principal Investigator
Feb 2015 – Jan 2020
UF Health Cancer Center Collaborative Cancer Related Seed Grant funded through the Florida Consortium of National Cancer Institute Centers Program
UF HEALTH SHANDS HOSPITAL · Principal Investigator
Jan 2015 ACTIVE
UF Health Cancer Center Bridge Seed Grant funded through the Florida Consortium of National Cancer Institute Centers Program
UF HEALTH SHANDS HOSPITAL · Principal Investigator
Sep 2013 ACTIVE
Chagnon Professorship – research in field of stem cell biology and bone marrow transplantation
UF FOU · Principal Investigator
Sep 2012 – Jan 2018
Seed award – Innes
UF FOU · Principal Investigator
Sep 2012 – Aug 2017
Oncology Nurse Educ
UF FOU · Principal Investigator
Feb 2012 – Mar 2018
Support of Lymphoma Research at UF Shands Cancer Center
UF FOU · Principal Investigator
Feb 2012 – Mar 2018
Sponholtz Family Cancer Research Fund – #F14006
UF FOU · Principal Investigator
Feb 2012 – Mar 2018
BAC Lung Research
UF FOU · Principal Investigator
Feb 2012 – Mar 2018
Women's Can Res
UF FOU · Principal Investigator
Feb 2012 – Dec 2018
Support Cancer Care Coordinators and Patient Navigators
UF FOU · Principal Investigator
Feb 2012 ACTIVE
Davis Cancer Endowment – #F014842
UF FOU · Principal Investigator
Feb 2012 – Nov 2018
Rinker Chair
UF FOU · Principal Investigator
Aug 2011 – Mar 2018
Small Cell Cancer Equipment and Research Competition
UF FOU · Principal Investigator
Apr 2010 – Mar 2018
Prostate – UFF #016581
UF FOU · Principal Investigator
Apr 2010 – Mar 2018
Winter Fund
UF FOU · Principal Investigator
Jan 2008 – Mar 2018
Ocala Royal Dames lectures, forums UFF fund #008336
UF FOU · Principal Investigator
Jul 2007 – Mar 2018
Lung Cancer Research at UFSCC
UF FOU · Principal Investigator
Jul 2007 – Mar 2018
Support Cancer Research at UFSCC
UF FOU · Principal Investigator
Jul 2007 ACTIVE
Breast Cancer Research
UF FOU · Principal Investigator
Jul 2007 – Apr 2018
Salkewicz Fund for Leukemia Research
UF FOU · Principal Investigator
Jan 2007 – Oct 2018
Consolidated UFSCC Research
UF FOU · Principal Investigator
Jan 2007 – Mar 2018
Pancreatic Cancer Research
UF FOU · Principal Investigator
Dec 2006 – May 2018
Holloway research support for breast cancer at UFSCC
UF FOU · Principal Investigator
Dec 2006 – Mar 2018
UFSCC Endowment to support cancer center research
UF FOU · Principal Investigator
Dec 2006 – Nov 2017
Irwin Cancer Research at UFSCC
UF FOU · Principal Investigator
Dec 2006 – Nov 2017
Krumins fund for stomach cancer research at UFSCC
UF FOU · Principal Investigator
Jul 2006 ACTIVE
21st Century Research & Economic Development Investment Program (REDIP)
STATE UNIV SYS OF FL BOARD OF GOVERNORS · Project Manager
Mar 2006 ACTIVE
Davis Cancer Researach Equipment
UF FOU · Principal Investigator

Contact Details

Phones:
Business:
(352) 273-8143